WA
BDSI

WFG Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

WFG Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,000
Closed -$12K – 2373
2013
Q2 		$12K Buy
+3,000
New +$14.1K ﹤0.01% 1407

Other funds holding BDSI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

WFG Advisors's BDSI Position: Q3 2013 in Review

WFG Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2013, closing a stake of 3,000 shares — an estimated $12K sold.

WFG Advisors first reported a position in BDSI in Q2 2013 and held it in 1 quarter. The position peaked at $12K in Q2 2013. 68 funds tracked by Wall St. Rank hold BDSI as of Q3 2013.

  • WFG Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2013 after selling out during the quarter.
  • WFG Advisors sold 3,000 BioDelivery Sciences International, Inc. shares in Q3 2013, an estimated $12K.
  • WFG Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 1 quarter.
  • WFG Advisors's BioDelivery Sciences International, Inc. position peaked at $12K in Q2 2013.
  • 68 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2013.

Based on WFG Advisors's 13F filing for Q3 2013, filed 31 Oct 2013.